📝 Paper alert: Targeting #DIPG tumor #metabolism, #mitochondria and #hypoxia to #radiosensitize tumors 🧠 ☢️ url.au.m.mimecastprotect.com/s/sijcCmO5gl...
@hannsshen.bsky.social
@hannsshen.bsky.social
November 28, 2024 at 4:33 AM
📝 Paper alert: Targeting #DIPG tumor #metabolism, #mitochondria and #hypoxia to #radiosensitize tumors 🧠 ☢️ url.au.m.mimecastprotect.com/s/sijcCmO5gl...
@hannsshen.bsky.social
@hannsshen.bsky.social
RPRM (Reprimo) triggers SCF(FBXW11)-mediated DNA-PKcs degradation to block non-homologous end joining and radiosensitize tumors https://www.biorxiv.org/content/10.64898/2025.12.14.694167v1
December 17, 2025 at 12:47 AM
RPRM (Reprimo) triggers SCF(FBXW11)-mediated DNA-PKcs degradation to block non-homologous end joining and radiosensitize tumors https://www.biorxiv.org/content/10.64898/2025.12.14.694167v1
RPRM (Reprimo) triggers SCF(FBXW11)-mediated DNA-PKcs degradation to block non-homologous end joining and radiosensitize tumors https://www.biorxiv.org/content/10.64898/2025.12.14.694167v1
December 17, 2025 at 12:47 AM
RPRM (Reprimo) triggers SCF(FBXW11)-mediated DNA-PKcs degradation to block non-homologous end joining and radiosensitize tumors https://www.biorxiv.org/content/10.64898/2025.12.14.694167v1